Kinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgery

Respir Physiol Neurobiol. 2011 Sep 15;178(2):256-60. doi: 10.1016/j.resp.2011.06.019. Epub 2011 Jun 28.

Abstract

Receptor-of-Advanced-Glycation-End-products (RAGE) and Surfactant-Protein-type-B (SPB) are reported as lung injury markers. Unlike SPB, RAGE is secreted by several tissues, so that RAGE specificity as lung injury marker is questionable. We measured SPB and RAGE in 19 patients undergoing major vascular abdominal surgery. SPB and RAGE were measured before mechanical ventilation (T0), at 1st (T1), 2nd (T2) and, when present, 3rd (T3) hour of mechanical ventilation, and 1h after extubation (T(POST)). Last data during mechanical ventilation, either T2 or T3, are reported as T(END). SPB and RAGE values were normalized for total protein (SPB(N) and RAGE(N)). SPB(N) and RAGE(N) increments from T0 to T(END) were 56.2 [39.1] ng/mg (mean [75-25 percentile]) and 10.6[7.1] pg/mg, respectively. SPB values increased progressively during mechanical ventilation, whereas RAGE values increased at T(1) but not thereafter. SPB(N) increase (T(END)-T0), but not RAGE(N), was related to ΔPaO(2)/FiO2 changes during mechanical ventilation (r=0.575, p=0.01). Plasma RAGE(N) and SPB(N) kinetics in patients undergoing major vascular surgery are different.

Publication types

  • Comparative Study

MeSH terms

  • Acute Lung Injury / blood
  • Acute Lung Injury / etiology
  • Acute Lung Injury / pathology
  • Aged
  • Antigens, Neoplasm / blood*
  • Biomarkers / blood
  • Disease Progression
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mitogen-Activated Protein Kinases / blood*
  • Mitogen-Activated Protein Kinases / pharmacokinetics
  • Pulmonary Surfactant-Associated Protein B / blood*
  • Pulmonary Surfactant-Associated Protein B / pharmacokinetics
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic*
  • Respiration, Artificial* / adverse effects
  • Respiration, Artificial* / standards
  • Vascular Surgical Procedures* / adverse effects

Substances

  • Antigens, Neoplasm
  • Biomarkers
  • Pulmonary Surfactant-Associated Protein B
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic
  • Mitogen-Activated Protein Kinases